Abstract:There are no standards about the delineation of clinical target volume of upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU).This study aims to explore the high-risk local recurrence areas for UTUC patients stratified by primary tumor locations and in order to provide implications for the CTV design. All the UTUC patients who were followed up in our center after radical nephroureterectomy between 2010 and 2016 were retrospectively enrolled. The patterns of first discovered failure were assessed, and local recurrence sites (soft tissue relapse within the retroperitoneal field of exenteration and regional lymph nodes) were evaluated. All of the local recurrence sites were identified by MRI, CT, or PETCT. Three hundred twenty-nine patients with radical nephroureterectomy were enrolled in our study. The median follow up time was 45m (4-110m). Sixty-five patients experienced local recurrence. The median time from surgery to local relapse was 7m (range 1-48m). Local recurrence was the first event in 26 (57.8%) patients, the other 19 patients (42.2%) also had metastasis. We studied the detailed relapse site images of 45 patients. A total of 152 sites of local relapse were observed in 45 patients. The median relapse sites of each patient was 2 (1-10). The average number of positive nodes per patient was 3.4. Among the 152 relapse sites, lymphatic recurrence was the dominant recurrence type (90.1%, 137 sites), and the others were soft tissue recurrence (9.9%, 15 sites). We stratified all the patients into 3 groups according to their tumor location. Para-aorta lymph node region has the highest recurrence rates in all of the patients. The recurrence rates in this region account for 85% in renal pelvic and upper ureter tumor, 75% and 74% in middle and lower ureter tumor. The distribution of recurrent LN in middle and lower ureter tumors were much lower (below mid level of L2) than renal pelvic and upper ureter tumors (superior bonder of L1). Para-aorta recurrence in patients with left-sided UTUC almost occurred in LPA region. While the right-sided UTUC had higher para-aorta recurrence rate in RPC and AC region. Recurrence of internal and external iliac lymph node region was rare (<10%) in all the UTUC patients. In all of the soft tissue recurrence sites, the kidney fossa relapse accounted for 33.3% (5 sites); urecter tumor bed recurrence accounted for 66.7% (10 sites). Lymph node recurrences were the most common recurrence sites in UTUC patients after surgery. Para-aortic lymph node region was the common recurrence lymph regions in UTUC patients. Right-sided UTUC had different local relapse pattern compared with left-sided UTUC in this region. Recurrence in internal and external iliac lymph node region was rare (<10%) in all the UTUC patients. Delineate CTV according to the primary tumor locations can include more than 90% recurrence regions and decrease the radiation areas compared with conventional CTV.

Variant histology is associated with more non‐urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy

Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy

Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy

Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis

Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients with Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy.

[Clinicopathologic Characteristics and Prognosis of Upper Tract Urothelial Carcinoma: an Analysis of 368 Radical Nephroureterectomy Specimens].

Impact of variant histology in the prognosis of non‑muscle invasive bladder cancer with low‑tumor burden: A propensity score‑matched analysis with conventional urothelial carcinoma

Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis

Intravesical Recurrence after Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes.

The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study

Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma

Prognostic impact of variant histology in bladder cancer: Would early and aggressive treatment shift the paradigm?

Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy

Sensitivity of Initial Biopsy or Transurethral Resection of Bladder Tumor(s) for Detecting Histological Variants on Radical Cystectomy

[Prognostic Factors for Intravesical Recurrence after Surgery for Upper Tract Urothelial Carcinoma in Renal Transplant Recipients].

Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China

Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan

[Prognostic Factors of Patients with T2N0M0 Upper Tract Urothelial Carcinoma: a Single-Center Retrospective Study of 235 Patients].

Muscle-invasive upper tract urothelial carcinoma predicts invasive bladder recurrence tumor

Patterns of Local Failure after Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma: Association with Primary Tumor Locations and Implications for the Clinical Target Volume Design of Adjuvant Radiation Therapy

Pattern and Risk Factors of Local Recurrence after Nephroureterectomy for Upper Tract Urothelial Carcinoma